One Per Day Inflammatory Response

Supplement for healthy inflammatory response*
One Per Day Inflammatory Response
One Per Day Inflammatory Response
One Per Day Inflammatory Response
One Per Day Inflammatory Response

One Per Day Inflammatory Response

One Per Day + Inflammatory Response is a one-per-day capsule designed to support a healthy inflammatory response^* with CurQfen. This formula also provides Joint Shield™ 5-LOXIN Advanced®, a highly concentrated herbal extract that helps improve joint comfort within 7 days† and continues to improve over time.‡

1 capsule per day

Ingredients: CurQfen®, Joint Shield™ 5-LOXIN Advanced®, Vitamin D

Gluten Free

Supplement Facts
Our Ingredients Explained
5-LOXIN® ADVANCED

What is 5-LOXIN Advanced?

5-LOXIN Advanced is a novel composition extracted from Boswellia serrata tree that produces a highly scented sap that has been a prized substance since ancient times. Boswellia serrata extract is deeply rooted in the ancient history of Boswellia serrata tree and contains boswellic acids. 5-LOXIN Advanced contains high concentrations of the boswellic acid, AKBA which is an important Boswellic acid that helps with occasional joint flare-ups.

Why do I need 5-LOXIN Advanced?

5-LOXIN Advanced is a joint health ingredient. Recent studies have shown that modern Boswellia serrata extracts provide powerful benefits in promoting joint comfort and joint health.

Where do I get 5-LOXIN Advanced?

There are no food sources of 5-Loxin Advanced, so you must get it from supplements.Osteo Bi-Flex’s Joint Shield 5-LOXIN® Advancedis a unique ingredient that contains AKBA, which is an important Boswellic acid that helps with occasional joint flare-ups. The oral bioavailability of AKBA from 5-LOXIN Advanced was found to be significantly higher in comparison with that of other commercially available Boswellia extracts[5].Osteo Bi-Flexis proud to serve you products withJoint Shield™ 5-LOXIN® Advancedthatshows improved joint comfort within 7 days!*◊

Badge #1 Pharmacist Recommended Brand 2022-2023 joint health U.S. News & World Report Pharmacy Times